TriRx Pharmaceutical Services is excited to announce the recent launch of our survey, Pharmaceutical Supply Chain Challenges & Opportunities Survey Report. Conducted in 2021, the survey gained insights into the current product lifecycle supply chain challenges experienced by innovator and generics pharmaceutical organizations, disruptions caused by the COVID-19 pandemic, and future market directions.
The results of this survey are an interesting window into both long-existing industry challenges, issues worsened by the volatility of the pandemic, and the evolutions of a changing market, withpharmaceutical executives sharing their positions ondosage form trends, ongoing serialization hurdles, unclear market demand, and more.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
TriRx Pharmaceutical Services is a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical market. Headquartered approximately 50 miles outside of New York City in Norwalk, Connecticut, they operate facilities providing state-of-the-art laboratory, manufacturing, packaging and warehousing capabilities. Founded and led by a team of pharmaceutical industry executives who have served as both contract service providers and customers, TriRx has a profound and multifaceted understanding of customer needs.